Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

GDC-0084 × CNS × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 74 Magnetic Resonance Spectroscopy 65 Specimen Handling 44 Radiotherapy 42 Radiosurgery 28 Cyclophosphamide 27 Radiation 22 pembrolizumab 21 Biopsy 19 Bevacizumab 16 Nivolumab 15 Carboplatin 14 Irinotecan 13 Etoposide 13 Vincristine 11 fludarabine 10 dinutuximab 10 Ipilimumab 10 abemaciclib 9 AZD 6244 9 X-Rays 8 Lomustine 8 trametinib 7 niraparib 7 Topotecan 7 Surgical Procedures, Operative 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Eflornithine 7 Cisplatin 7 Blood Specimen Collection 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07391215 2026-02-05

5G-PEARL

Institute of Cancer Research, United Kingdom

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡